Uswm LLC
Louisville, KY
- UEI
- NLTVUPB2NJL5
- CAGE
- 8PE79
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Other
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 4441 Springdale Rd, Louisville, KY 40241, USA
- Website
- usworldmeds.com
- Founded
- 2001
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Q500M MPC tilt/rcln sedeo pro | Veterans Integrated Service Network 7 | $11,088 | |
| Registration development program for lucemyra (lofexidine) label expansion for opioid withdrawal treatment in… | National Institute on Drug Abuse | $12,384,262 | |
| Development of lofexidine as a first-line non-opioid pharmacologic treatment for neonatal opioid withdrawal syndrome -… | National Institute on Drug Abuse | $14,731,796 |
About Uswm LLC
Uswm LLC is a for-profit limited liability company headquartered in Louisville, Kentucky, specializing in pharmaceutical development with a focused research and development approach targeting opioid withdrawal treatments. The company develops pharmaceutical products and provides pharmaceutical services to federal agencies, particularly within the healthcare and medical research domains. Registered in SAM.gov since June 18, 2020, Uswm LLC has established itself as a pharmaceutical research and development organization with specific expertise in creating non-opioid treatments for withdrawal symptoms across different patient populations.
Through its federal contract awards, Uswm LLC has primarily engaged with the Veterans Integrated Service Network (VISN) in delivering pharmaceutical products. The company has been awarded delivery orders under General Services Administration (GSA) Federal Supply Schedule contracts, specifically within the Pharmaceuticals and Drugs schedule (FSS-61-IB). Its contract awards have been predominantly non-set-aside contracts, with recent awards including a $11,087.90 delivery order from VISN 7 for specific pharmaceutical products. The contracts are typically structured as firm fixed-price arrangements with defined performance periods, demonstrating the company's capability to provide precise pharmaceutical deliverables to federal healthcare networks.
Uswm LLC has secured substantial federal grant awards from the National Institute on Drug Abuse (NIDA) and the National Institute of Neurological Disorders and Stroke, focusing on developing innovative treatments for opioid withdrawal across different patient populations. The company has received two significant cooperative agreement grants: a $14,583,710 grant to develop Lucemyra (lofexidine) for treating opioid withdrawal in adolescents, and a grant aimed at developing lofexidine as a first-line non-opioid treatment for Neonatal Opioid Withdrawal Syndrome (NOWS). These grants demonstrate Uswm LLC's commitment to addressing critical public health challenges related to opioid withdrawal across different age groups.
Uswm LLC holds multiple Federal Supply Schedule (FSS) Indefinite Delivery/Indefinite Quantity (IDIQ) contracts, including a significant multiple-award contract with a ceiling value of $25,812,235.30 under the Pharmaceuticals and Drugs schedule (FSS-61-IB). These contracts, awarded by Veterans Integrated Service Network 12, enable the procurement of various drugs, pharmaceuticals, and hematology-related products. The company's IDV contracts are multiple-award vehicles without specific set-aside designations, indicating their broad applicability across federal healthcare procurement needs. These contracts demonstrate Uswm LLC's capacity to provide pharmaceutical products and support federal healthcare procurement strategies, with contract periods extending through February 2026.
Contract vehicles
Quick answers
What is Uswm LLC's UEI?
Uswm LLC's Unique Entity ID (UEI) in SAM.gov is NLTVUPB2NJL5.
What is Uswm LLC's CAGE code?
Uswm LLC's CAGE code is 8PE79.
What is Uswm LLC's primary NAICS code?
Uswm LLC's primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).
Where is Uswm LLC located?
Uswm LLC's physical address in SAM.gov is 4441 Springdale Rd, Louisville, KY 40241, USA.
Is Uswm LLC registered in SAM.gov?
Yes. Uswm LLC's SAM.gov registration is active through May 15, 2027.
Which contract vehicles does Uswm LLC hold?
Uswm LLC holds a place on 1 federal contract vehicle: FSS-61-IB.
What is Uswm LLC's most recent federal award?
Uswm LLC's most recent federal contract award is Q500M MPC tilt/rcln sedeo pro (36C24725N0558), from Veterans Integrated Service Network 7, on April 21, 2025.
On GovTribe
See Uswm LLC's full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors